Nguyen Tam, Bjorkman Jonas, Paton Barbara C, Crane Denis I
Cell Biology Group, Eskitis Institute for Cell and Molecular Therapies, Griffith University, 170 Kessels Road, Brisbane, Queensland 4111, Australia.
J Cell Sci. 2006 Feb 15;119(Pt 4):636-45. doi: 10.1242/jcs.02776. Epub 2006 Jan 31.
In contrast to peroxisomes in normal cells, remnant peroxisomes in cultured skin fibroblasts from a subset of the clinically severe peroxisomal disorders that includes the biogenesis disorder Zellweger syndrome and the single-enzyme defect D-bifunctional protein (D-BP) deficiency, are enlarged and significantly less abundant. We tested whether these features could be related to the known role of microtubules in peroxisome trafficking in mammalian cells. We found that remnant peroxisomes in fibroblasts from patients with PEX1-null Zellweger syndrome or D-BP deficiency exhibited clustering and loss of alignment along peripheral microtubules. Similar effects were observed for both cultured embryonic fibroblasts and brain neurons from a PEX13-null mouse with a Zellweger-syndrome-like phenotype, and a less-pronounced effect was observed for fibroblasts from an infantile Refsum patient who was homozygous for a milder PEX1 mutation. By contrast, such changes were not seen for patients with peroxisomal disorders characterized by normal peroxisome abundance and size. Stable overexpression of PEX11beta to induce peroxisome proliferation largely re-established the alignment of peroxisomal structures along peripheral microtubules in both PEX1-null and D-BP-deficient cells. In D-BP-deficient cells, peroxisome division was apparently driven to completion, as induced peroxisomal structures were similar to the spherical parental structures. By contrast, in PEX1-null cells the majority of induced peroxisomal structures were elongated and tubular. These structures were apparently blocked at the division step, despite having recruited DLP1, a protein necessary for peroxisome fission. These findings indicate that the increased size, reduced abundance, and disturbed cytoplasmic distribution of peroxisomal structures in PEX1-null and D-BP-deficient cells reflect defects at different stages in peroxisome proliferation and division, processes that require association of these structures with, and dispersal along, microtubules.
与正常细胞中的过氧化物酶体相比,在临床上严重的过氧化物酶体疾病(包括生物发生障碍的泽尔韦格综合征和单酶缺陷的D-双功能蛋白(D-BP)缺乏症)的一个亚组患者的培养皮肤成纤维细胞中,残留的过氧化物酶体体积增大且数量明显减少。我们测试了这些特征是否可能与微管在哺乳动物细胞过氧化物酶体运输中的已知作用有关。我们发现,患有PEX1基因缺失的泽尔韦格综合征或D-BP缺乏症患者的成纤维细胞中的残留过氧化物酶体表现出聚集以及沿外周微管排列的丧失。对于具有泽尔韦格综合征样表型的PEX13基因缺失小鼠的培养胚胎成纤维细胞和脑神经元也观察到了类似的效果,而对于患有较轻PEX1突变纯合子的婴儿型雷夫叙姆病患者的成纤维细胞,观察到的效果则不太明显。相比之下,过氧化物酶体丰度和大小正常的过氧化物酶体疾病患者则未出现此类变化。稳定过表达PEX11β以诱导过氧化物酶体增殖,在很大程度上重新建立了PEX1基因缺失和D-BP缺乏细胞中过氧化物酶体结构沿外周微管的排列。在D-BP缺乏细胞中,过氧化物酶体分裂显然被驱动完成,因为诱导的过氧化物酶体结构与球形亲代结构相似。相比之下,在PEX1基因缺失细胞中,大多数诱导的过氧化物酶体结构是细长的管状。尽管已经募集了过氧化物酶体分裂所必需的蛋白DLP1,但这些结构显然在分裂步骤受阻。这些发现表明,PEX1基因缺失和D-BP缺乏细胞中过氧化物酶体结构的尺寸增大、数量减少以及细胞质分布紊乱反映了过氧化物酶体增殖和分裂不同阶段的缺陷,这些过程需要这些结构与微管结合并沿微管分散。